Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
Dose-ranging Double-blind, Placebo-controlled Efficacy Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92120
- Allergy Associates Medical Group, Inc.
-
-
Georgia
-
Savannah, Georgia, United States, 31409
- Aeroallergy Research Labs of Savannah, Inc.
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville
-
-
Massachusetts
-
North Dartmouth, Massachusetts, United States, 02747
- Northeast Medical Research Associates, Inc.
-
-
Mississippi
-
Jackson, Mississippi, United States, 39202
- Mississippi Asthma and Allergy Clinic
-
-
North Carolina
-
Raleigh, North Carolina, United States, 27607
- North Carolina Clinical Research
-
-
Oregon
-
Eugene, Oregon, United States, 97401
- Allergy and Asthma Research Group
-
Portland, Oregon, United States, 97213
- Allergy Associates Research Center
-
-
Texas
-
The Woodlands, Texas, United States, 77380
- Medical Research Network
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Persistent asthma for a minimum of six months duration that has been stable for at least four weeks
- Predicted FEV1 60-90%
- Demonstration of 12% airway reversibility
Exclusion Criteria:
- Continuous requirement for beta-blockers, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, anticholinergics and/or steroids other than those inhaled;
- Presence of clinically-significant non-asthmatic acute or chronic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Immune System Diseases
- Lung Diseases
- Hypersensitivity, Immediate
- Bronchial Diseases
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity
- Asthma
- Physiological Effects of Drugs
- Autonomic Agents
- Peripheral Nervous System Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Bronchodilator Agents
Other Study ID Numbers
Other Study ID Numbers
- IXR-204-25-167
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.